Page 3 - Nova Biomedical News Today

Nova Biomedical announces the launch of the Nova Max Pro Creatinine/eGFR Meter System in all CE countries. Nova Max Pro is an important new tool to improve kidney care through kidney function screening and early detection of kidney disease in point-of-care settings

Submitted by San Juan County

Per the research report published by MarketDataForecast, the Point-of-care diagnostic market is anticipated to be worth USD 39.69 billion by 2027, registering a

Point-of-Care Diagnostics Market to Expand at a CAGR of 4.7% from 2021 to 2028

CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Point of Care/ Rapid Diagnostics Market is expected to reach USD 75.5 billion by 2027 from an estimated USD 45.4 billion in 2022, at a CAGR of 10.7% from

The global blood gas and electrolyte analyzer market size reached US$ 1.85 Bn in 2021. By 2027, It will reach US$ 2.76 Bn, exhibiting a CAGR of 6.70% (2022-27).

Global Point of Care (PoC) Lipid Test Market is witnessing a surge in its market value over the years and this can be attributed to the rising obesity levels in the consumers. Data Bridge Market Research analyses that the point of care (POC) lipid test market will exhibit a CAGR of around 9.1% for the forecast perio...

Data Bridge Market Research completed a qualitative study titled “Point-of-Care-Ultrasound Device Market” with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy-to-grasp full analysis. The most up-to-date technology was used in conjunction with expert industry knowledge and pra...

/PRNewswire/ -- The Global Diabetes Care Devices Market was valued at USD 26.14 billion in 2021. It is projected to reach USD 45.09 billion by 2028, growing at...

LONDON, Nov. 1, 2022 /PRNewswire/ -- The Global Diabetes Care Devices Market was valued at USD 26.14 billion in 2021. It is projected to reach USD 45.09 billion by 2028, growing at a CAGR of